Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Br J Ophthalmol ; 105(10): 1415-1420, 2021 10.
Artigo em Inglês | MEDLINE | ID: mdl-32920528

RESUMO

PURPOSE: To evaluate the various patterns of subretinal fluid (SRF) in eyes with age-related macular degeneration (AMD) in the absence of macular neovascularisation (MNV) and to assess the long-term outcomes in these eyes. METHODS: This retrospective study included only eyes with non-neovascular AMD and associated SRF. Eyes with evidence of MNV were excluded. Spectral-domain optical coherence tomography (SD-OCT) was obtained at baseline and at follow-up, and qualitative and quantitative SD-OCT analysis of macular drusen including drusenoid pigment epithelial detachment (PED) and associated SRF was performed to determine anatomic outcomes. RESULTS: Forty-five eyes (45 patients) were included in this analysis. Mean duration of follow-up was 49.7±36.7 months. SRF exhibited three different morphologies: crest of fluid over the apex of the drusenoid PED, pocket of fluid at the angle of a large druse or in the crypt of confluent drusen or drape of low-lying fluid over confluent drusen. Twenty-seven (60%) of the 45 eyes with fluid displayed collapse of the associated druse or drusenoid PED and 24 (53%) of the 45 eyes developed evidence of complete or incomplete retinal pigment epithelial and outer retinal atrophy. CONCLUSION: Non-neovascular AMD with SRF is an important clinical entity to recognise to avoid unnecessary anti-vascular endothelial growth factor therapy. Clinicians should be aware that SRF can be associated with drusen or drusenoid PED in the absence of MNV and may be the result of retinal pigment epithelial (RPE) decompensation and RPE pump failure.


Assuntos
Degeneração Macular , Líquido Sub-Retiniano , Inibidores da Angiogênese/uso terapêutico , Angiofluoresceinografia , Seguimentos , Humanos , Injeções Intravítreas , Degeneração Macular/tratamento farmacológico , Descolamento Retiniano/diagnóstico , Descolamento Retiniano/tratamento farmacológico , Drusas Retinianas/diagnóstico , Pigmentos da Retina/uso terapêutico , Estudos Retrospectivos , Líquido Sub-Retiniano/diagnóstico por imagem , Tomografia de Coerência Óptica , Fator A de Crescimento do Endotélio Vascular , Acuidade Visual , Degeneração Macular Exsudativa/diagnóstico , Degeneração Macular Exsudativa/tratamento farmacológico
2.
Jpn J Infect Dis ; 64(4): 330-2, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21788711

RESUMO

Dengue is currently the most important arboviral disease in the world, particularly in tropical countries in which the environmental conditions favor the development and proliferation of the mosquito vector. Dengue hemorrhagic fever presents in two phases: an initial phase, which is characterized by sudden onset of fever and a variety of nonspecific signs and symptoms, and a critical phase, which is characterized by the recovery from fever and development of hemorrhagic symptoms and circulatory insufficiency. This report documents a case of splenic rupture in a patient with dengue hemorrhagic fever who developed hypovolemic shock and subsequently died. Although splenic rupture is a known complication of other acute infections, it is a rare complication of dengue; therefore, it may be misdiagnosed. In the case described here, the poor outcome mainly resulted from the sudden onset of complications; the patient died of splenic rupture less than 24 h after admission, and the cause of death was confirmed at necropsy.


Assuntos
Diagnóstico Tardio , Dengue Grave/complicações , Ruptura Esplênica/complicações , Dor Abdominal/etiologia , Adulto , Evolução Fatal , Humanos , Masculino , Ruptura Espontânea/complicações , Ruptura Espontânea/cirurgia , Dengue Grave/virologia , Choque/etiologia , Esplenectomia , Ruptura Esplênica/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...